Cited by 113Hormonal and reproductive studiesSmoking Behavior and CessationSperm and Testicular Function

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 14 sources its claims cite is checked for support yet.

Endogenous testosterone levels and smoking in men. The fifth Tromsø study

Open access
Svartberg, Johan, Jorde, Rolf·2007·International Journal of Andrology

Abstract

Summary: Smoking is a risk factor of coronary heart disease (CHD), while the role of testosterone in the development of CHD is controversial. The reported effects of cigarette smoking on testosterone levels in men are conflicting, and smoking may be an important confounding factor when evaluating the relationship between testosterone levels and CHD. Thus, the objective of the present study was to examine the associations of smoking status and number of cigarettes smoked per day with total and free testosterone levels in a cross‐sectional population‐based study of 3427 men participating in the fifth Tromsø study. Total testosterone, luteinizing hormone, follicle‐stimulating hormone and sex hormone‐binding globulin levels were measured with immunoassay while free testosterone levels were calculated. Waist circumference was also measured and two standardized questionnaires were completed, including smoking status and number of cigarettes smoked. The data were analysed with analysis of variance and covariance and multiple regression analysis. Smoking men had significantly higher levels of total and free testosterone compared with men who never smoked (p < 0.001 and <0.01 respectively). Both total and free testosterone levels increased significantly with increasing number of cigarettes smoked daily (p < 0.001). Smoking men had 15% higher total and 13% higher free testosterone levels compared with men who never smoked. Thus, smoking seems to be an important confounding factor when evaluating testosterone levels, and could possibly mask borderline hypogonadism.

Checked 2026-11-05 · 1 reference not checked yet

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

In the fifth Tromsø study, smoking men had significantly higher total and free testosterone levels than never-smokers, and levels rose with the number of cigarettes smoked daily. The authors conclude smoking is an important confounding factor when evaluating testosterone levels and could mask borderline hypogonadism.

Key findings

  • Smokers had higher total testosterone than never-smokers (15.5 vs. 13.6 nmol/L, p < 0.001) and higher free testosterone (285 vs. 269 pmol/L, p < 0.01).
  • Smoking men had 15% higher total and 13% higher free testosterone levels compared with men who never smoked.
  • Total and free testosterone increased significantly with increasing number of cigarettes smoked daily, both before and after adjustment for age and waist circumference (p < 0.001).
  • Previous smokers had total testosterone almost identical to never-smokers (13.5 vs. 13.6 nmol/L); smoking was also an independent positive predictor of SHBG (p < 0.001).

Methods

  • Cross-sectional, population-based study of 3427 men from the fifth Tromsø study (2001); total testosterone was measured in 3447 men, and smoking status was recorded in 3427.
  • Total testosterone, LH, FSH, and SHBG were measured by immunoassay; free testosterone was calculated from total testosterone and SHBG using a fixed albumin value. Waist circumference and self-administered questionnaires on smoking, physical activity, and alcohol were used.
  • Analyses included Student’s t-test, analysis of variance/covariance, and multiple linear regression, with two-tailed p < 0.05 considered significant.

Limitations

  • The paper states hormone levels were based on a single sample drawn between 08.30 and 18.30 h, not preferably in the morning due to diurnal variation; adjusting for sampling time did not change associations.
  • The paper states free testosterone was calculated, not measured, though the calculation was reported as reliable; smoking status and number of cigarettes were self-reported, so misclassification cannot be excluded.
  • The paper states the most important limitation is the cross-sectional design, so the direction of associations cannot be determined.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2605.2006.00720.x

Cites

31 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

9 Own result · 8 Sources not found · 8 Own method · 5 Own interpretation · 4 No full text of the sources

  • It may state two separate claims as one. 12
  • Probably not a substantial claim. 8
16 of 16
  • The paper relies on this without support.

    Smoking may be an important confounding factor when evaluating the relationship between testosterone levels and CHD.

    “As smoking may be an important confounding factor when evaluating the relationship between testosterone levels and CHD, it is important to better understand the associations between smoking and testosterone levels.”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Research works printed but not linked: 1

  1. Critchley J., 2004, Smoking cessation for the secondary prevention of coronary hearth disease, Cochrane Database of Systematic Reviews, 1, CD003041

Cited by

Sorted by citations

See all 113

Metadata

Authors
Svartberg, J., & Jorde, R.
Affiliations
University Hospital of North Norway (NO)
Corresponding author
Svartberg, Johan
Venue
International Journal of Andrology
Publisher
Wiley
Published
2006-11-29
Volume
30
Issue
3
Pages
137-143
ISSN
  • 0105-6263 (ISSN-L)
  • 1365-2605
OpenAlex
W1999593787
Cited by
111
References
27
Citations by year
2026: 5 · 2025: 2 · 2024: 12 · 2023: 6 · 2022: 8 · 2021: 11 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 5 · 2013: 2 · 2012: 5
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • International Journal of Andrology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords
testosterone, smoking, free testosterone, total testosterone, cigarette smoking, coronary artery disease, confounding factor, hypogonadism, luteinizing hormone, follicle-stimulating hormone, sex hormone-binding globulin, men, waist circumference
MeSH terms
Adult, Aged, Analysis of Variance, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Regression Analysis, Sex Factors, Smoking, Testosterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review